1 / 31

Learning objectives

Management of Seizure Disorders Mark Kotlarewsky, MD FACP Department of Medicine Medstar Washington Hospital Center. Learning objectives. Understand the definition of seizure, epilepsy Understand the types of treatment, both medical and surgical

nevina
Télécharger la présentation

Learning objectives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Management of Seizure DisordersMark Kotlarewsky, MD FACPDepartment of MedicineMedstar Washington Hospital Center

  2. Learning objectives • Understand the definition of seizure, epilepsy • Understand the types of treatment, both medical and surgical • Understand notable side effects of common antiepileptic drugs • Understand treatment and management of epilepsy-related comorbidities • Management of antiepileptic drugs in women • Management of status epilepticus

  3. Conflicts of interest • None

  4. Definitions • seizure: abnormal, excessive, or synchronous neuronal activity in the cerebral cortex • 1-2 min, altered consciousness is common, confusion/fatigue after an episode, increased HR, tonic-clonic movement, paresthesias, aphasia • epilepsy: two or more unprovoked seizures

  5. Seizure types • Partial • simple - does not impair awareness (eg. epileptic auras, jacksonian march) • complex - impairs awareness by typically spreading to one or both temporal lobes • secondarily generalized - when simple type spreads to involve both hemispheres diffusely • Generalized • primary - tonic-clonic • absence - impairment of consciousness • myoclonic - muscle contractions in rapid succession without consciousness impairment

  6. Epilepsy types • partial • temporal lobe - mesial temporal sclerosis • generalized • juvenile myoclonic - morning myoclonus, absence

  7. Mesial temporal sclerosis

  8. Epilepsy-related comorbidities • psychiatric disorders - depression, suicide, anxiety • cognitive problems - visual/verbal memory, attention • osteoporosis, heart disease, hypertension, stroke, obesity, obstructive sleep apnea • sudden death

  9. Choosing an antiepileptic drug (AED) • effectiveness for seizure type • side effects • drug-drug interactions • comorbid conditions • age • gender • lifestyle, patient preferences • cost

  10. Choosing an AED by epilepsy type • partial - nearly all, particularly lamotrigine, carbamazepine, oxcarbazepine, levetiracetam • generalized - lamotrigine, levetiracetam, topiramate, zonisamide, NOT carbamazepine, gabapentin, pregabalin as they can sometimes exacerbate this type • absence - ethosuximide, valproate • atypical absence, myoclonic, atonic - valproate, lamotrigine, levetiracetam

  11. Initiating/adding treatment • usually one drug, rather than two or more • 2nd drug should have different mechanism, different side effect profile • published therapeutic serum ranges should not be used if patient is doing well clinically (?) • unclear whether generic substitutions lead to poorer control

  12. Mechanisms • inhibitory transmission (benzodiazepines, clobazam, phenobarbital, tiagabine, vigabatrin) • sodium channels (carbamazepine, lacosamide, lamotrigine, oxcarbazepine, phenytoin, rufinamide) • calcium channels (ethosuximide) • potassium channels (ezogabine) • excitatory transmission (perampanel) • multiple mechanisms (felbamate, valproate, gabapentin, levetiracetam, topiramate)

  13. AED side effects • sedation, ataxia • folate deficiency • renal metabolism - gabapentin, levetiracetam, pregabalin, topiramate, zonisamide • hepatic metabolism - carbamazepine, phenytoin, valproate • elderly: • YES - gabapentin, lamotrigine, levetiracetam • NO - oxcarbazepine, phenytoin, carbamazepine

  14. AED side effects • suicide - levetiracetam, topiramate, vigabatrin • Stevens Johnson Synrome, toxic epidermal necrolysis, drug rash - phenytoin, carbamazepine (allele screening hlab1502 in asians), oxacarbazepine, primidone, phenobarbital, zonisamide, lamotrigine • osteoporosis - especially with: phenytoin, carbamazepine, phenobarbital, primidone and valproate; consider checking bone mineral density after five years • use with caution in patients with cardiac conduction pathology: lacosamide, phenytoin, ezogabine

  15. AED side effects • weight loss - zonisamide, felbamate, topiramate • weight gain - pregabalin, gabapentin, valproate • insomnia - felbamate, lamotrigine • nephrolithiasis - topiramate, zonisamide • valproic acid - exacerbates sx of polcystic ovarian disease • carbamazepine - induces own metabolism

  16. Oral contraceptives • carbamazepine, phenytoin, phenobarbital, primidone tend to decrease contraceptive serum levels (also felbamate, topiramate, oxcarbazepine, rufinamide, clobazam, perampanel) • no interaction with levetiracetam, valproate • reduced lamotrigine concentrations, which then go up during the week of inactive tablets

  17. Pregnancy • 4-6% rate of teratogenicity, 2-3x general population • seizure control more important than teratogenicity • aim: monotherapy at lowest dose for control • avoid older AED’s: phenytoin, phenobarbital, valproate; latter two associated with oral cleft, cardiac, urinary tract, and neural tube defects, lower IQ • topiramate: oral cleft, hypospadias • better: lamotrigine, carbamazepine, levetiracetam, oxcarbazepine, gabapentin, but monitor levels closely

  18. Pregnancy • induces AED metabolism, esp. lamotrigine • phenytoin, carbamazepine, primidone, phenobarbital: hemorrhage in newborn due to vitamin K deficiency • folate: give 4mg starting 1-3 months prior to conception if on carbamazepine, valproic acid; standard dose for others

  19. Drug-drug interactions • phenytoin, carbamazepine, primidone, phenobarb, (oxcarbazepine, topiramate) • warfarin, OCP’s, anti-infectives, anti-cancer • between AED’s (eg. carbamazepine reduces lamotrigine levels, valproate increases them) • alcohol: 1-2 drinks in well-controlled patient OK, highest risk of seizure 7-48hrs after cessation of alcohol

  20. Alternative tx • vagal nerve stimulation, deep brain stimulation of anterior nucleus of thalamus, responsive neurostimulator • epilepsy surgery - high rate of cure in patients with known lesions (eg. tumor, vascular malformation, mesial temporal sclerosis) • ketogenic/modified Atkins diet (hi fat, low carb)

  21. STATUS! • convulsive • continued seizure activity >30 min; practically, initiate treatment within 5 min • lorazepam • fosphenytoin • intubate, sedate, additional AED

  22. STATUS! • nonconvulsive • 20% treated for convulsive status epilepticus, develop EEG seizure • start management if altered mental status more than 20min post cessation of convulsive episode • sensitivity of EEG increases longer it is done (95% at 48 hrs) • paradoxical improvement with low dose benzodiazepines

  23. Case #1 • 35 yom w h/o simple partial seizure, failed levetiracetam due to side effects, recently switched to carbamazepine, presents c/o recurrent seizure

  24. What to do? • switch to lamotrigine • add lamotrigine • switch to ethosuximide • switch back to levetiracetam • check carbamazepine level

  25. Case #2 • 70yof w h/o osteoarthritis,1st degree AV block, hepatic disease, deep venous thrombosis on warfarin was diagnosed with partial seizure disorder and started on primidone; patient was lost to follow up but showed up in the ED with another DVT and a subtherapeutic INR

  26. What to do? • switch to valproic acid • switch to gabapentin • continue primidone, low INR is due to warfarin noncompliance • switch to lacosamide • switch to carbamazepine

  27. Case #3 • 31yof w h/o nephrolithiasis, renal insufficiency, and partial seizure disorder taking valproic acid and OCP is interested in having a child; aside from stopping her OCP...

  28. What do you recommend? • folic acid and carbamazepine • folic acid and lamotrigine • phenytoin • folic acid and topiramate • folic acid and valproic acid

  29. Case #4 • 21yom w h/o juvenile myoclonic epilepsy presents to the ED with uncontrolled seizure; after 15minutes of observed tonic-clonic seizure, and 6mg of IV lorazepam, the patient’s clinical status does not improve

  30. What to do next? • IV valproic acid, 30mg/kg at 3mg/kg/min • fosphenytoin 18 PE/kg at150PE/min • phenytoin 18mg/kg at 50mg/min • lorazepam 2mg • propofol 2-5 mg/kg bolus

  31. Thank you!

More Related